HIV Drug Resistance Testing Still Important
HIV Drug Resistance Testing Still Important
Carmen de Mendoza
Puerta de Hierro University Hospital, Madrid, Spain
*Correspondence: Carmen de Mendoza, Email not available
Abstract
The proportion of HIV-infected individuals on antiretroviral therapy exhibiting undetectable viremia has increased up to 90% in most HIV clinics, mainly as a result of the introduction of the newest antiretrovirals, namely integrase strand transfer inhibitors (INSTI). Conversely, the proportion of HIV-positive patients experiencing virological failure has drastically declined, making the request for drug resistance testing less frequent (Cescon A, et al. J Acquir Immune Defic Syndr. 2014;65:107-14).
